Prescriber Update - Medsafe
Prescriber Update 2010; 31(2) June 12 • Height, weight and appetite should be recorded at least every six months. Patients who are not gaining height or …
Download Prescriber Update - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Nine Cases of Omeprazole Allergy: Cross-Reactivity …
www.jiaci.org© 2009 Esmon Publicidad J Investig Allergol Clin Immunol 2009; Vol. 19(1): 57-60 CASE REPORTS Nine Cases of Omeprazole Allergy: Cross-Reactivity Between Proton Pump Inhibitors T Lobera, B Navarro, MD Del Pozo, I González, A Blasco, R Escudero,
New Zealand Datasheet 1 PRODUCT NAME Dr …
www.medsafe.govt.nzNew Zealand Datasheet 1 PRODUCT NAME Dr Reddy’s Omeprazole 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Omeprazole 20 mg capsules 3 PHARMACEUTICAL FORM
KLACID Abbott - Modern Medicine
www.meppo.comABBOTT-KLACID - p.2/7 Contraindications Clarithromycin is contra-indicated in patients with known hypersensitivity to macrolide antibiotic drugs
K blockers. Your doctor may need to monitor you …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER . Omeprazole 20mg Capsules . omeprazole . Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
PACKAGE LEAFLET - Medicines
www.medicines.org.ukDo not take Omeprazole if you are taking a medicine containing nelfinavir (used to treat HIV infection). Tell your doctor or pharmacist if you are taking, have recently taken, or might take any of the
Stability of Extemporaneously Compounded …
www.medisca.comMEDISCA.COM/studies 121 1 1 2 1 111 1 A MEDISCA Technical Report Stability of Extemporaneously Compounded Omeprazole 2 mg/mL in …